{"id":"W3164932383","doi":"10.1016/s2213-2600(21)00222-8","title":"Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":271,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Montreal Heart Institute; Centre hospitalier universitaire de Québec; Université de Montréal; Université Laval","funders":"NYU Grossman School of Medicine; National Institutes of Health; Fondation Institut de Cardiologie de Montréal; May and Samuel Rudin Family Foundation; Gilead Sciences; Bayer; Institut de Cardiologie de Montréal; Servier; Bill and Melinda Gates Foundation; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Merck","keywords":"Medicine; Placebo; Clinical endpoint; Clinical trial; Internal medicine; Randomized controlled trial; Physical therapy; Alternative medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001450213,0.0003370154,0.0008595154,0.00005853383,0.000538361,0.00002181793,0.0004046404,0.000164649,0.0001088131],"category_scores_gemma":[0.001254938,0.0001994097,0.0001556299,0.0001933444,0.0003415543,0.000009124078,0.00009616997,0.0003599442,0.000004902419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004829657,"about_ca_system_score_gemma":0.0004158355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000802748,"about_ca_topic_score_gemma":0.0004708792,"domain_scores_codex":[0.9975504,0.0008250507,0.0005211857,0.0003479472,0.0002900293,0.0004653508],"domain_scores_gemma":[0.9976869,0.0004371228,0.0003121502,0.000945308,0.0004392019,0.000179274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9766355,0.0006215935,0.0005285373,0.00006274373,0.0005561177,0.00001003515,0.0003866816,0.00009173317,0.01026007,0.00005516279,0.009865218,0.0009266337],"study_design_scores_gemma":[0.8727427,0.004941629,0.0001086446,0.00005030369,0.0003419395,0.000002928115,0.0009707418,0.00005314591,0.006460362,0.00001596675,0.1140706,0.000241015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868681,0.001999426,0.001224858,0.00166894,0.0002638842,0.006121264,0.00006778438,0.00003868926,0.001747043],"genre_scores_gemma":[0.986576,0.0001357844,0.00008530104,0.009068085,0.001224254,0.001189052,0.0009350065,0.00005886524,0.0007276614],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1042054,"threshold_uncertainty_score":0.8131691,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07250634528563542,"score_gpt":0.3457538682921317,"score_spread":0.2732475230064963,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}